|
CN107875396A
|
|
Temozolomide injectable composition and preparation method thereof
|
|
CN108164459A
|
|
The preparation method of Sorafenib Tosylate crystal form III
|
|
CN108017630A
|
|
A kind of preparation method of small specific surface product Pa Boxini free alkalis
|
|
WO2015113314A1
|
|
New crystal form of 3-(4-amino-1,3-dihydro-1-oxo-2h-isoindole-2-yl)-2,6-piperidinedione and preparation method therefor
|
|
CN104016966A
|
|
Novel 3-(4-amino-1,3-dihydro-1-oxo-2H-isoindole-2-yl)-2,6-piperidinedione crystal forms and preparation method thereof
|
|
WO2015051500A1
|
|
Pyrrolotriazine derivative, preparation method therefor, and uses thereof
|
|
CN104016983A
|
|
Pyrrolotriazine derivatives and preparation method and application thereof
|
|
WO2013078973A1
|
|
Large particle diameter dasatinib and preparation and use thereof
|
|
WO2013017100A1
|
|
Imatinib mesylate tablet
|
|
CN103211760A
|
|
Clevidipine butyrate intralipid and preparation method thereof
|
